Literature DB >> 12959294

Trough concentrations of cyclosporine in blood following administration with grapefruit juice.

M P Ducharme1, R Provenzano, M Dehoorne-Smith, D J Edwards.   

Abstract

Components of grapefruit juice have been shown to inhibit CYP3A4 activity, the enzyme involved in cyclosporine metabolism. Eleven medically stable patients (seven males, four females) receiving cyclosporine following kidney transplantation were instructed to take their usual dose of cyclosporine with water for 1 week (Phase 1), with grapefruit juice (8 ounces) for 1 week (Phase 2) and again with water for 1 week (Phase 3). Trough blood samples were obtained at the end of each phase for measurement of cyclosporine concentration using a specific monoclonal whole blood radioimmunoassay. Cyclosporine trough concentrations averaged 116.9 +/- 51.6 ng ml(-1) in the first phase, 145.3 +/- 44.7 ng ml(-1) with grapefruit juice (P < 0.05 compared with the first and third phases) and 111.2 +/- 56.1 ng ml(-1) in the third phase. Cyclosporine concentrations increased in 8 of 11 patients when given with grapefruit juice (mean increase 32%; range -4 to 97%) and declined in 10 of 11 when subjects resumed taking cyclosporine with water (mean decrease 27%). These results suggest that grapefruit juice increases trough concentrations of cyclosporine in blood, possibly by inhibiting pre-hepatic gut wall metabolism, and could be useful in optimizing therapy with this drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959294      PMCID: PMC1364619          DOI: 10.1111/j.1365-2125.1993.tb00395.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance.

Authors:  B Edgar; D Bailey; R Bergstrand; G Johnsson; C G Regårdh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  First-pass metabolism of cyclosporin by the gut.

Authors:  J C Kolars; W M Awni; R M Merion; P B Watkins
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.

Authors:  A Miniscalco; J Lundahl; C G Regårdh; B Edgar; U G Eriksson
Journal:  J Pharmacol Exp Ther       Date:  1992-06       Impact factor: 4.030

4.  Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

Authors:  T Kronbach; V Fischer; U A Meyer
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

5.  Pharmacokinetic interaction between cyclosporin and diltiazem.

Authors:  J Brockmöller; H H Neumayer; K Wagner; W Weber; G Heinemeyer; H Kewitz; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

Authors:  P B Watkins; S A Wrighton; E G Schuetz; D T Molowa; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

7.  Evidence for pre-hepatic metabolism of oral cyclosporine in children.

Authors:  K Hoppu; O Koskimies; C Holmberg; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

9.  Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans.

Authors:  P A Soons; B A Vogels; M C Roosemalen; H C Schoemaker; E Uchida; B Edgar; J Lundahl; A F Cohen; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1991-10       Impact factor: 6.875

10.  Cyclosporin-erythromycin interaction in renal transplant patients.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

View more
  24 in total

1.  Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors:  H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 2.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

3.  Stereoselective interaction of manidipine and grapefruit juice: a new twist on an old tale.

Authors:  Brian Tomlinson; Moses S S Chow
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Effect of grapefruit juice on cyclosporine pharmacokinetics.

Authors:  A Majeed; A Kareem
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 6.  The influence of food on the absorption and metabolism of drugs: an update.

Authors:  L Williams; D P Hill; J A Davis; D T Lowenthal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

7.  Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.

Authors:  A Ohnishi; H Matsuo; S Yamada; H Takanaga; S Morimoto; Y Shoyama; H Ohtani; Y Sawada
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 8.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 9.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

10.  In vitro inhibition of midazolam and quinidine metabolism by flavonoids.

Authors:  H R Ha; J Chen; P M Leuenberger; A U Freiburghaus; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.